The global prevalence of diabetes continues to rise, projected to impact 700 million individuals by 2045. This increase parallels a significant growth in diabetes-associated complications, with ...
A new study found that a novel mRNA-based therapy that targets a protein called RUNX1 may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR), a disease caused by a ...
The following is a summary of “Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis,” published in the November 2024 issue ...